Evotec SE Sponsored ADR EVO

Healthcare Biotechnology

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

NDAQ:EVO - Post by User

Evotec SE Sponsored ADR

<< Previous

Bullboard Posts

Next >>

Post by whytestockson Apr 24, 2024 5:15pm

60 Views

Post# 36005942

US Companies Moving the Markets, Evening edition <br>Wed, Ap

News; $EVO US Companies Moving the Markets, Evening edition <br>Wed, Apr 24, 2024 as of 4:00 pm ETA look at the top 10 most actives in the United States Chicken Soup for the Soul Entertainment Inc. (CSSE) rose 179.3% to $0.4253 on volume of 213,352,319 shares Tesla Inc. (TSLA) rose 12.1% to $162.13 on volume of 179,967,315 shares PROSHARES TRUST (SQQQ) fell 0.8% to $11.81 on volume of...EVO - US Companies Moving the Markets, Evening edition <br>Wed, Apr 24, 2024 as of 4:00 pm ET

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment